These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 8289961
21. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Verstraete M, Brown BG, Chesebro JH, Ekeström S, Harker LA, Henderson AH, Jewitt DE, Oliver MF, Sleight P. Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223 [Abstract] [Full Text] [Related]
22. [Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass]. Sagnol P, Delahaye JP. Presse Med; 1991 Feb 23; 20(7):287-90. PubMed ID: 1826353 [No Abstract] [Full Text] [Related]
23. Invited commentary. Hiratzka LF. Ann Thorac Surg; 2010 Nov 23; 90(5):1521-2. PubMed ID: 20971253 [No Abstract] [Full Text] [Related]
24. Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion. Chong BH. Aust N Z J Med; 1992 Dec 23; 22(6):645-6. PubMed ID: 1489286 [No Abstract] [Full Text] [Related]
25. Prevention of atherosclerosis in coronary-artery bypass grafts. Fuster V, Vorchheimer DA. N Engl J Med; 1997 Jan 16; 336(3):212-3. PubMed ID: 8988902 [No Abstract] [Full Text] [Related]
27. The role of clopidogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation. Kayacioglu I, Gunay R, Saskin H, Idiz M, Sensoz Y, Ates M, Tangurek B, Alper AT, Demirtas MM, Yekeler I. Heart Surg Forum; 2008 Jan 16; 11(3):E152-7. PubMed ID: 18583285 [Abstract] [Full Text] [Related]
31. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient? Halkes PH, Algra A. Cerebrovasc Dis; 2007 Jan 16; 24 Suppl 1():107-11. PubMed ID: 17971645 [Abstract] [Full Text] [Related]
32. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention. Prescrire Int; 2000 Jun 16; 9(47):83-5. PubMed ID: 11010749 [Abstract] [Full Text] [Related]
33. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Cannon CP, Mehta SR, Aranki SF. Ann Thorac Surg; 2005 Aug 16; 80(2):768-79. PubMed ID: 16039260 [Abstract] [Full Text] [Related]
34. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Zimmermann N, Gams E, Hohlfeld T. Eur J Cardiothorac Surg; 2008 Jul 16; 34(1):93-108. PubMed ID: 18448350 [Abstract] [Full Text] [Related]
36. Medical treatment after peripheral bypass surgery over the past decade. van Hattum ES, Tangelder MJ, Huis in 't Veld MA, Lawson JA, Algra A, Moll FL. Eur J Vasc Endovasc Surg; 2011 Jun 16; 41(6):805-13. PubMed ID: 21349747 [Abstract] [Full Text] [Related]
37. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year]. Rohn V, Pirk J, Mach T. Cor Vasa; 1993 Jun 16; 35(4):162-4. PubMed ID: 8403942 [Abstract] [Full Text] [Related]
38. Dipyridamole plus aspirin and hemodialysis graft patency. Hentschel DM. N Engl J Med; 2009 Aug 13; 361(7):720-1; author reply 721. PubMed ID: 19681176 [No Abstract] [Full Text] [Related]
39. [Dipyridamole after aortocoronary bypass--treatment or tradition]. Isakov A, Shapira I. Harefuah; 1995 Feb 15; 128(4):225-6. PubMed ID: 7744333 [No Abstract] [Full Text] [Related]